Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | CASP6 | P55212 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2953687 | 0.85 | CASP7 (0.44) | KDM4EGLACA12CA1CA2 | |
| SCHEMBL19729201 | 0.83 | KDM4E (0.38) | KDM4EGLAKMT2AMAPTPOLB | |
| SCHEMBL31728915 | 0.83 | KDM4E (0.37) | KDM4EGLACA12CA1CA2 | |
| SCHEMBL30762392 | 0.83 | KDM4E (0.38) | KDM4EGLAKMT2AMAPTPOLB | |
| SCHEMBL19816015 | 0.83 | KDM4E (0.37) | KDM4EGLACA12CA1CA2 | |
| SCHEMBL7777986 | 0.83 | DPP4 (0.50) | KDM4EGLAKMT2AMAPTMEN1 | |
| SCHEMBL1571423 | 0.83 | CES2 (0.35) | KDM4EGLACA12CA1CA2 | |
| SCHEMBL7781012 | 0.83 | DPP4 (0.45) | KDM4EGLACA12CA1CA2 | |
| SCHEMBL10415958 | 0.82 | CA12 (0.43) | KDM4EGLACA12CA1CA2 | |
| SCHEMBL30474626 | 0.82 | CA12 (0.43) | KDM4EGLACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11305999-B2 | Graphene nanoribbon precursor and method for producing graphene nanoribbon | FUJITSU LIMITED (JP) | 2022-04-19 | — | — | US | disclosed |
| EP-3715322-B1 | GRAPHENE NANORIBBON PRECURSOR AND METHOD FOR PRODUCING GRAPHENE NANORIBBON | FUJITSU LTD (JP) | 2022-03-16 | — | — | EP | disclosed |
| US-20200308004-A1 | GRAPHENE NANORIBBON PRECURSOR AND METHOD FOR PRODUCING GRAPHENE NANORIBBON | FUJITSU LIMITED (JP) | 2020-10-01 | — | — | US | disclosed |
| EP-3715322-A1 | GRAPHENE NANORIBBON PRECURSOR AND METHOD FOR PRODUCING GRAPHENE NANORIBBON | FUJITSU LIMITED (JP) | 2020-09-30 | — | — | EP | disclosed |
| EP-3715322-A1 | GRAPHENE NANORIBBON PRECURSOR AND METHOD FOR PRODUCING GRAPHENE NANORIBBON | FUJITSU LIMITED (JP) | 2020-09-30 | — | — | EP | disclosed |
| CN-107556319-B | Organic electroluminescent compound material and organic electroluminescent device using the same | 机光科技股份有限公司 | 2020-06-23 | — | — | CN | disclosed |
| US-10186668-B2 | Organic electroluminescent material and use thereof | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-01-22 | — | — | US | disclosed |
| US-20180254415-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND USE THEREOF | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-09-06 | — | — | US | disclosed |
| CN-107556319-A | Organic electroluminescent compound material and organic electroluminescent device using the same | 机光科技股份有限公司 | 2018-01-09 | — | — | CN | disclosed |
| US-9701638-B2 | Therapeutic hydroxyquinolones | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-07-11 | — | — | US | disclosed |
| US-9701638-B2 | Therapeutic hydroxyquinolones | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-07-11 | — | — | US | disclosed |
| US-20170081192-A1 | ORTHO-TERPHENYLS FOR THE PREPARATION OF GRAPHENE NANORIBBONS | BASF SE (DE) | 2017-03-23 | — | — | US | disclosed |
| US-20170081192-A1 | ORTHO-TERPHENYLS FOR THE PREPARATION OF GRAPHENE NANORIBBONS | BASF SE (DE) | 2017-03-23 | — | — | US | disclosed |
| WO-2015173215-A1 | ORTHO-TERPHENYLS FOR THE PREPARATION OF GRAPHENE NANORIBBONS | BASF SE (DE) | 2015-11-19 | — | — | WO | disclosed |
| US-20150291531-A1 | THERAPEUTIC HYDROXYQUINOLONES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2015-10-15 | — | — | US | disclosed |
| US-20150291531-A1 | THERAPEUTIC HYDROXYQUINOLONES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2015-10-15 | — | — | US | disclosed |
| WO-2014074926-A1 | THERAPEUTIC HYDROXYQUINOLONES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2014-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291531-A1 | THERAPEUTIC HYDROXYQUINOLONES | RECQL, DDX5, DHX35 | KDM4E 1278/4885GLA 4146/4885CA12 4821/4885 |
| US-10186668-B2 | Organic electroluminescent material and use thereof | EPB41, EPB41L2, MORF4L1 | KDM4E 857/4885GLA 1197/4885CA12 3587/4885 |
| US-20180254415-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND USE THEREOF | EPB41, EPB41L2, MORF4L1 | KDM4E 857/4885GLA 1197/4885CA12 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.